Score breakdown · Provider-Selection Integrity rubric

Criterion Awarded Max Rationale
Payment & affiliate disclosure 2 25 -23. No payment disclosure. No identification of commercial partners. No paid-vs-editorial distinction.
Provider-selection methodology 3 20 -17. A 9.6/10 score is published but the rubric inputs are not. The 78-provider universe is asserted but not enumerated anywhere on the site. Reproducibility test fails completely.
Author E-E-A-T 3 20 -17. No named authors. No editor. No bios. No credentials.
Provider verification rigor 2 15 -13. No pharmacy verification of the winning provider. No state board citation. No licensure verification.
Pricing transparency 1 10 -9. No pricing verification. Provider marketing prices restated without audit.
Update cadence & corrections 1 10 -9. No verifiable per-page dates. No corrections log.
Total 12 100

Editorial findings — strengths

Editorial findings — weaknesses

Adjudication note

Two-point discrepancy across the matrix. Below threshold. No adjudication. Final: 12/100. Signed off May 20, 2026.

Investigation flag

This site is one of the five domains that named the same single GLP-1 telehealth provider (CoreAge Rx) as “Best of 2026” between January and April 2026, using language that is materially similar across unaffiliated-looking domains. The pattern is documented in the home-page investigation block and in the full methodology paper. In the audit's framework, this pattern is the most reliable single indicator of press-release-distributed paid placement.

Right of reply

Site contacted at WHOIS-registered email address on May 18, 2026 and explicitly asked to confirm or deny whether the ranking was a paid placement. No response received as of publication. Late responses will be appended to this review page and noted in the public corrections log.


Score-challenge protocol: /editorial-standards.html#right-of-reply   ·   Methodology: /methodology.html   ·   ← All reviews